Evaluation of Changes in Macular Perfusion Detected by Optical Coherence Tomography Angiography following 3 Intravitreal Monthly Bevacizumab Injections for Diabetic Macular Edema in the IMPACT Study.

Ayman G ElnahryAhmed A Abdel-KaderKarim A RaafatKhaled Elrakhawy

Published in: Journal of ophthalmology (2020)

OCTA is a useful noninvasive tool for quantitative evaluation of macular perfusion changes following DME treatment. This trial is registered with NCT03246152.

Keyphrases

diabetic retinopathy
optical coherence tomography
age related macular degeneration
contrast enhanced
study protocol
cataract surgery
clinical trial
phase iii
high resolution
vascular endothelial growth factor
phase ii
randomized controlled trial
ultrasound guided
platelet rich plasma
open label
endothelial cells